Tech Company Financing Transactions
bioAffinity Technologies Funding Round
Private investors invested in a $4 million Series A funding round for bioAffinity Technologies. The round closed on 7/21/2017.
Transaction Overview
Company Name
Announced On
7/21/2017
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for commercialization and further development of additional cancer tests and novel therapeutics.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
22211 W Interstate 10 1206
San Antonio, TX 78257
USA
San Antonio, TX 78257
USA
Phone
Website
Email Address
Overview
bioAffinity Technologies, Inc. is a privately held developmental-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The Company develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Steven Girgenti
Chief Executive Officer
Maria Zannes
Chief Medical Officer
Vivienne Rebel
VP - R & D
William Bauta
Browse more venture capital transactions:
Prev: 7/21/2017: PayClip venture capital transaction
Next: 7/21/2017: Trevi Therapeutics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs